Details
Current Best Practice in Interventional Cardiology
1. Aufl.
138,99 € |
|
Verlag: | Wiley-Blackwell |
Format: | |
Veröffentl.: | 03.11.2009 |
ISBN/EAN: | 9781444314458 |
Sprache: | englisch |
Anzahl Seiten: | 240 |
DRM-geschütztes eBook, Sie benötigen z.B. Adobe Digital Editions und eine Adobe ID zum Lesen.
Beschreibungen
<i>Current Best Practice in Interventional Cardiology</i> addresses the questions which challenge clinicians involved with interventional procedures. Helpfully organized into four sections, the text addresses; coronary artery disease, non-coronary interventions, left ventricular failure and the latest advances in imaging technologies, and provides authoritative guidance on the current recommendations for best practice. <p>Containing contributions from an international team of opinion leaders, this new book reviews the key advances in equipment, techniques and therapeutics and is an accessible reference for all hospital-based specialists.</p>
Part I Coronary artery disease. <p>· Acute coronary syndrome – <i>Marco Roffi, Zurich, Switzerland, Pierre-Frédéric Keller, Geneva, Switzerland</i>.</p> <p>· Modern coronary stenting – <i>Stéphane Cook/Stephan Windecker, Otto Hess, Bern, Switzerland</i>.</p> <p>- DES.</p> <p>- Passive modern stents.</p> <p>- Late thrombosis.</p> <p>- Stenting of nonsignificant lesions (plaque sealing).</p> <p>- Comparison with medical treatment or bypass surgery.</p> <p>- Bioactive stents.</p> <p>· Chronic total occlusion – <i>Yaron Almagor, Jerusalem, Israel</i>.</p> <p>· Nonrevascularization therapy – <i>Jean-Paul Schmid, Bern, Switzerland</i>.</p> <p>- Shock wave therapy.</p> <p>- Spinal stimulation.</p> <p>- Coronary sinus restriction.</p> <p>.</p> <p><br /> Part II Noncoronary interventions.</p> <p>· Percutaneous valve replacement or repair – <i>Hélène Eltchaninoff, Rouen, France</i>.</p> <p>· PFO closure – <i>Bernhard Meier, Bern Switzerland</i>.</p> <p>· ASD and VSD closure – <i>tentatively: David Hildick Smith, London, UK</i>.</p> <p>· Carotid angioplasty – <i>Sri Iyer, New York, USA</i>.</p> <p>· Alcohol ablation of hyperthrophic cardiomyopathy – <i>Otto Hess, Bern, Switzerland</i>.</p> <p><br /> .</p> <p><br /> Part III Treatment of left ventricular failure.</p> <p>· Biventricular pacing – <i>Etienne Delacrétaz, Bern Switzerland</i>.</p> <p>· Percutaneous left ventricular assist devices – <i>Pim de Feyter, Rotterdam, NL</i> .</p> <p>· Stem cell therapy – <i>Andreas Zeiher, Frankfurt, Germany</i>.</p> <p>· Drug therapy in conjunction with interventions – <i>Roger Hullin, Bern, Switzerland</i>.</p> <p>.</p> <p><br /> Part IV Cardiovascular imaging.</p> <p>· Computed tomography (CT) for screening and follow-up – <i>Stephan Achenbach, Erlangen, Germany</i>.</p> <p>· Magnetic resonance (MR) for functional testing and interventional guidance – <i>Andreas Wahl, Bern, Switzerland</i>.</p> <p>· Optical coherence tomography (OCT) – <i>Jean-François Surmely, Aarau, Switzerland</i>.</p> <p>· Intravascular ultrasound (IVUS) – <i>Peter J. Fitzgerald, Stanford, CA, USA</i></p>
Bernhard Meier, MD, FACC, FESC<br /> <p>Professor and Chairman<br /> </p> <p>Department of Cardiology<br /> </p> <p>University Hospital<br /> </p> <p>3010 Bern<br /> </p> <p>Switzerland</p>